172 related articles for article (PubMed ID: 26052432)
1.
Xiao J; Wang Q; Bircsak KM; Wen X; Aleksunes LM
Toxicol Res (Camb); 2015 May; 4(3):695-706. PubMed ID: 26052432
[TBL] [Abstract][Full Text] [Related]
2. Placental BCRP/ABCG2 Transporter Prevents Fetal Exposure to the Estrogenic Mycotoxin Zearalenone.
Szilagyi JT; Gorczyca L; Brinker A; Buckley B; Laskin JD; Aleksunes LM
Toxicol Sci; 2019 Apr; 168(2):394-404. PubMed ID: 30576553
[TBL] [Abstract][Full Text] [Related]
3. Localization of the placental BCRP/ABCG2 transporter to lipid rafts: Role for cholesterol in mediating efflux activity.
Szilagyi JT; Vetrano AM; Laskin JD; Aleksunes LM
Placenta; 2017 Jul; 55():29-36. PubMed ID: 28623970
[TBL] [Abstract][Full Text] [Related]
4. Genetic and Dietary Regulation of Glyburide Efflux by the Human Placental Breast Cancer Resistance Protein Transporter.
Bircsak KM; Gupta V; Yuen PY; Gorczyca L; Weinberger BI; Vetrano AM; Aleksunes LM
J Pharmacol Exp Ther; 2016 Apr; 357(1):103-13. PubMed ID: 26850786
[TBL] [Abstract][Full Text] [Related]
5. Anandamide down-regulates placental transporter expression through CB2 receptor-mediated inhibition of cAMP synthesis.
Szilagyi JT; Composto-Wahler GM; Joseph LB; Wang B; Rosen T; Laskin JD; Aleksunes LM
Pharmacol Res; 2019 Mar; 141():331-342. PubMed ID: 30610963
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of the placental BCRP/ABCG2 transporter in response to hypoxia signaling.
Francois LN; Gorczyca L; Du J; Bircsak KM; Yen E; Wen X; Tu MJ; Yu AM; Illsley NP; Zamudio S; Aleksunes LM
Placenta; 2017 Mar; 51():57-63. PubMed ID: 28292469
[TBL] [Abstract][Full Text] [Related]
7. BCRP/
Wen X; Kozlosky D; Zhang R; Doherty C; Buckley B; Barrett E; Aleksunes LM
Drug Metab Dispos; 2021 Aug; 49(8):629-637. PubMed ID: 34074729
[TBL] [Abstract][Full Text] [Related]
8. Expression and functional activity of breast cancer resistance protein (BCRP, ABCG2) transporter in the human choriocarcinoma cell line BeWo.
Ceckova M; Libra A; Pavek P; Nachtigal P; Brabec M; Fuchs R; Staud F
Clin Exp Pharmacol Physiol; 2006; 33(1-2):58-65. PubMed ID: 16445700
[TBL] [Abstract][Full Text] [Related]
9. Protective role of the placental efflux transporter BCRP/ABCG2 in the relationship between prenatal cadmium exposure, placenta weight, and size at birth.
Barrett ES; Rivera-Núñez Z; Getz K; Ohman-Strickland P; Zhang R; Kozlosky D; Doherty CL; Buckley BT; Brunner J; Miller RK; O'Connor TG; Aleksunes LM
Environ Res; 2023 May; 225():115597. PubMed ID: 36863650
[TBL] [Abstract][Full Text] [Related]
10. The ABC transporter BCRP/ABCG2 is a placental survival factor, and its expression is reduced in idiopathic human fetal growth restriction.
Evseenko DA; Murthi P; Paxton JW; Reid G; Emerald BS; Mohankumar KM; Lobie PE; Brennecke SP; Kalionis B; Keelan JA
FASEB J; 2007 Nov; 21(13):3592-605. PubMed ID: 17595345
[TBL] [Abstract][Full Text] [Related]
11. Single nucleotide polymorphisms result in impaired membrane localization and reduced atpase activity in multidrug transporter ABCG2.
Mizuarai S; Aozasa N; Kotani H
Int J Cancer; 2004 Mar; 109(2):238-46. PubMed ID: 14750175
[TBL] [Abstract][Full Text] [Related]
12. Induction of cells differentiation and ABC transporters expression by a myco-estrogen, zearalenone, in human choriocarcinoma cell line (BeWo).
Prouillac C; Videmann B; Mazallon M; Lecoeur S
Toxicology; 2009 Sep; 263(2-3):100-7. PubMed ID: 19580841
[TBL] [Abstract][Full Text] [Related]
13. Regulation of the placental BCRP transporter by PPAR gamma.
Lin Y; Bircsak KM; Gorczyca L; Wen X; Aleksunes LM
J Biochem Mol Toxicol; 2017 May; 31(5):. PubMed ID: 27879033
[TBL] [Abstract][Full Text] [Related]
14. Fetal Membranes Contribute to Drug Transport across the Feto-Maternal Interface Utilizing the Breast Cancer Resistance Protein (BCRP).
Kammala A; Benson M; Ganguly E; Radnaa E; Kechichian T; Richardson L; Menon R
Life (Basel); 2022 Jan; 12(2):. PubMed ID: 35207454
[TBL] [Abstract][Full Text] [Related]
15. Regulation of BCRP/ABCG2 expression by progesterone and 17beta-estradiol in human placental BeWo cells.
Wang H; Zhou L; Gupta A; Vethanayagam RR; Zhang Y; Unadkat JD; Mao Q
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E798-807. PubMed ID: 16352672
[TBL] [Abstract][Full Text] [Related]
16. Wild-type breast cancer resistance protein (BCRP/ABCG2) is a methotrexate polyglutamate transporter.
Volk EL; Schneider E
Cancer Res; 2003 Sep; 63(17):5538-43. PubMed ID: 14500392
[TBL] [Abstract][Full Text] [Related]
17. Placental BCRP transporter reduces cadmium accumulation and toxicity in immortalized human trophoblasts.
Zhang R; Walker L; Wen X; Doherty C; Gorczyca L; Buckley B; Barrett ES; Aleksunes LM
Reprod Toxicol; 2023 Oct; 121():108466. PubMed ID: 37660740
[TBL] [Abstract][Full Text] [Related]
18. Buprenorphine, Norbuprenorphine, R-Methadone, and S-Methadone Upregulate BCRP/ABCG2 Expression by Activating Aryl Hydrocarbon Receptor in Human Placental Trophoblasts.
Neradugomma NK; Liao MZ; Mao Q
Mol Pharmacol; 2017 Mar; 91(3):237-249. PubMed ID: 27974484
[TBL] [Abstract][Full Text] [Related]
19. Hop-derived prenylflavonoids are substrates and inhibitors of the efflux transporter breast cancer resistance protein (BCRP/ABCG2).
Tan KW; Cooney J; Jensen D; Li Y; Paxton JW; Birch NP; Scheepens A
Mol Nutr Food Res; 2014 Nov; 58(11):2099-110. PubMed ID: 25044854
[TBL] [Abstract][Full Text] [Related]
20. Interactions between riluzole and ABCG2/BCRP transporter.
Milane A; Vautier S; Chacun H; Meininger V; Bensimon G; Farinotti R; Fernandez C
Neurosci Lett; 2009 Mar; 452(1):12-6. PubMed ID: 19146924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
